Research on mechanisms for vascular action of adrenomedullin
肾上腺髓质素血管作用机制研究
基本信息
- 批准号:10218202
- 负责人:
- 金额:$ 42.05万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research on Priority Areas
- 财政年份:1998
- 资助国家:日本
- 起止时间:1998 至 2002
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Adrenomedullin is a vasodilatory peptide and major source of circulating adrenomedullin is the vascular wall. The vascular action of adrenomedullin was at first considered to solely due elevated cAMP production, I. e., endothelium-independent vasodilation. However, we found that endothelial denudation substantially reduced the vasodilatory action of adrenomedullin in rodent aortic rings. Furthermore, this adrenomedullin-induced endothelium-dependent vasorelaxation is exerted mostly through activation of the phosphatydil inositol 3-kinase (PI3-K)/Akt pathway. It has been well established that this pathway is involved in various important actions such as anti-apoptosis and tissue protection as well as activation of endothelial nitric oxide synthase (eNOS).Furthermore, we have reported that expression of the adrenomedullin gene is upregulated by hypoxia. Adrenomedullin abrogates ischemia/reperfusion renal injury. Studies using adrenomedullin gene knockout mice revealed that adrenomedullin plays an important role in vascular formation in embryos. Adrenomedullin transgenic mice were resistant to ischemia/reperfusion renal injury and adrenomedullin knockout mice vice versa. These findings suggest that endogenous adrenomedullin may play an important role as a tissue survival factor.
肾上腺髓质素是一种血管舒张肽,其主要来源是血管壁。肾上腺髓质素的血管作用最初被认为仅仅是由于cAMP的产生升高,即内皮非依赖性血管舒张。然而,我们发现内皮剥脱大大降低了肾上腺髓质素在啮齿动物主动脉环中的血管舒张作用。此外,这种肾上腺髓质素诱导的内皮依赖性血管松弛主要是通过激活磷酸二醇肌醇3-激酶(PI3-K)/Akt通路来实现的。已证实该通路参与多种重要作用,如抗凋亡和组织保护以及内皮型一氧化氮合酶(eNOS)的激活。此外,我们已经报道了缺氧会上调肾上腺髓质素基因的表达。肾上腺髓质素消除肾缺血/再灌注损伤。对肾上腺髓质素基因敲除小鼠的研究表明,肾上腺髓质素在胚胎血管形成中起重要作用。肾上腺髓质素转基因小鼠对缺血/再灌注肾损伤具有抵抗性,而肾上腺髓质素敲除小鼠对缺血/再灌注肾损伤具有抵抗性。这些发现提示内源性肾上腺髓质素可能作为组织存活因子发挥重要作用。
项目成果
期刊论文数量(88)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Nishimatsu H, Suzuki E, Nagata D, Moriyama N, Satonaka H, Walsh K, Sata M, Kangawa K, Matsuo H, Goto A, Kitamura T, Hirata Y: "Adrenomedullin induces endothelium-dependent vasorelaxation via the phosphatidylinositol 3 kinase/akt-dependent pathway in rat a
Nishimatsu H、Suzuki E、Nagata D、Moriyama N、Satonaka H、Walsh K、Sata M、Kangawa K、Matsuo H、Goto A、Kitamura T、Hirata Y:“肾上腺髓质素通过磷脂酰肌醇 3 激酶/akt 诱导内皮依赖性血管舒张
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kakoki M,Hirata Y, et al.: "Effects of tetrahydrobiopterin on endothelial dysfunction in rats with ischemic acute renal failure."J Am Soc Nephrol. 11. 301-309 (2000)
Kakoki M、Hirata Y 等人:“四氢生物蝶呤对缺血性急性肾衰竭大鼠内皮功能障碍的影响。”J Am Soc Nephrol。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Suzuki E,Hirata Y, et al.: "Reentry into the cell cycle of contact-inhibited vascular endothelial cells by a phosphatase inhibitor : possible involvement of extracellular signal-regulated kinase and phosphatidylinositol 3-kinase."J Biol Chem. 275. 3637-36
Suzuki E、Hirata Y 等人:“通过磷酸酶抑制剂重新进入接触抑制的血管内皮细胞的细胞周期:可能涉及细胞外信号调节激酶和磷脂酰肌醇 3-激酶。”J Biol Chem。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Nishimatsu H, Hirata Y, Hayakawa H, Nagata D, Satonaka H, Suzuki E, Horie S, Takeuchi T, Ohta N, Homma Y, Minowada S, Nagai R, Kawabe K, Kitamura T: "Effects of intracavemous administration of adrenomedullin on erectile function in rats"Peptides. 22. 1913
Nishimatsu H、Hirata Y、Hayakawa H、Nagata D、Satonaka H、Suzuki E、Horie S、Takeuchi T、Ohta N、Homma Y、Minowada S、Nagai R、Kawabe K、Kitamura T:“肾上腺髓质素的海绵体内给药对
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Sata M, Hirata Y et al.: "Hematopoietic stem cells differentiate into vascular cells that particiate in the pathogenesis of atherosclerosis"Nature Med. 8. 403-409 (2002)
Sata M、Hirata Y 等人:“造血干细胞分化为参与动脉粥样硬化发病机制的血管细胞”Nature Med。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HIRATA Yasunobu其他文献
HIRATA Yasunobu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HIRATA Yasunobu', 18)}}的其他基金
Development of novel therapy for atherosclerosis using adipose tissue-derived stem cells
利用脂肪组织干细胞开发动脉粥样硬化新疗法
- 批准号:
22590822 - 财政年份:2010
- 资助金额:
$ 42.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Studies on visualization of arteriosclerotic lesion using vascular cell-derived vasoactive substances
利用血管细胞源性血管活性物质对动脉硬化病变进行可视化研究
- 批准号:
16390217 - 财政年份:2004
- 资助金额:
$ 42.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Identification and regulation of differentiation In bone marrow -derived vascular progenitor cells
骨髓源性血管祖细胞分化的鉴定和调控
- 批准号:
13557061 - 财政年份:2001
- 资助金额:
$ 42.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Role of apoptosis of vascular endothelial cells In atherosclerosis
血管内皮细胞凋亡在动脉粥样硬化中的作用
- 批准号:
13470141 - 财政年份:2001
- 资助金额:
$ 42.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Establishment of nitric oxide measurement in exhaled air and its clinical application.
呼出气中一氧化氮测量方法的建立及其临床应用
- 批准号:
09670700 - 财政年份:1997
- 资助金额:
$ 42.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of sensitve assay of NO and its clinical application
NO灵敏检测方法的研制及其临床应用
- 批准号:
07557055 - 财政年份:1995
- 资助金额:
$ 42.05万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Studies on mechanisms of atrial natriuretic peptide secretion
心房钠尿肽分泌机制的研究
- 批准号:
61570405 - 财政年份:1986
- 资助金额:
$ 42.05万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
Nitric Oxide Metabolism in Acute Traumatic Brain Injury
急性创伤性脑损伤中的一氧化氮代谢
- 批准号:
10055288 - 财政年份:2020
- 资助金额:
$ 42.05万 - 项目类别:
Ultra-low Fouling and Nitric Oxide Releasing Intravascular Catheters for Prevention of Thrombosis and Infection
用于预防血栓形成和感染的超低污垢和一氧化氮释放血管内导管
- 批准号:
9908906 - 财政年份:2020
- 资助金额:
$ 42.05万 - 项目类别:
Maximizing transfusion efficacy through nitric oxide enhancement strategies
通过一氧化氮增强策略最大化输血功效
- 批准号:
10009828 - 财政年份:2019
- 资助金额:
$ 42.05万 - 项目类别:
The Role of Nitric oxide/cyclic Guanosine Monophosphate (NO/cGMP) Signaling in Arteriovenous Fistula Maturation
一氧化氮/环磷酸鸟苷 (NO/cGMP) 信号在动静脉瘘成熟中的作用
- 批准号:
10083108 - 财政年份:2019
- 资助金额:
$ 42.05万 - 项目类别:
Oral Microbiome, Nitric oxide Metabolism, and Oral and Cardiometabolic Health
口腔微生物组、一氧化氮代谢以及口腔和心脏代谢健康
- 批准号:
10221890 - 财政年份:2019
- 资助金额:
$ 42.05万 - 项目类别:
The Role of Nitric oxide/cyclic Guanosine Monophosphate (NO/cGMP) Signaling in Arteriovenous Fistula Maturation
一氧化氮/环磷酸鸟苷 (NO/cGMP) 信号在动静脉瘘成熟中的作用
- 批准号:
10302273 - 财政年份:2019
- 资助金额:
$ 42.05万 - 项目类别:
The Role of Nitric oxide/cyclic Guanosine Monophosphate (NO/cGMP) Signaling in Arteriovenous Fistula Maturation
一氧化氮/环磷酸鸟苷 (NO/cGMP) 信号在动静脉瘘成熟中的作用
- 批准号:
9910167 - 财政年份:2019
- 资助金额:
$ 42.05万 - 项目类别:
Red Blood Cell Endothelial Nitric Oxide Attenuates Insulin Resistance
红细胞内皮一氧化氮减弱胰岛素抵抗
- 批准号:
10181020 - 财政年份:2018
- 资助金额:
$ 42.05万 - 项目类别:
Red Blood Cell Endothelial Nitric Oxide Attenuates Insulin Resistance
红细胞内皮一氧化氮减弱胰岛素抵抗
- 批准号:
9767272 - 财政年份:2018
- 资助金额:
$ 42.05万 - 项目类别: